DuPont Pharma Has "A Number Of Bidders"; Company Still Considering IPO

DuPont has had several companies express interest in purchasing its pharmaceutical business, DuPont Pharmaceuticals Chairman Richard DeSchutter told an April 11 meeting with securities analysts.